SAFESCIENCE INC
S-3, EX-5.1, 2000-08-04
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: SAFESCIENCE INC, S-3, 2000-08-04
Next: SAFESCIENCE INC, S-3, EX-23.2, 2000-08-04



                      [MCDERMOTT, WILL & EMERY LETTERHEAD]



                                          August 3, 2000



SafeScience, Inc.
31 St. James Avenue, 8th Floor
Boston, MA  02116

         Re:      Registration Statement on Form S-3
                  ----------------------------------

Dear Ladies & Gentlemen:

                  At your request, we have examined the form of Registration
Statement on Form S-3 (the "Registration Statement"), to be filed by
SafeScience, Inc., a Nevada corporation (the "Company"), with the Securities and
Exchange Commission in connection with the registration under the Securities Act
of 1933 for resale of an aggregate of up to 317,414 shares (the "Shares") of
Common Stock, par value $.01 per share, of the Company (the "Common Stock")
issuable upon exercise of outstanding warrants (the "Warrants"). The Shares may
be sold from time to time for the account of certain stockholders of the
Company.

                  We have examined the proceedings heretofore taken by the
Company in connection with the authorization, issuance and sale of the
securities referred to above.

                  Based on the foregoing, and assuming that the full
consideration for each Share issuable upon exercise of the Warrants is received
by the Company in accordance with the terms of the Warrants, it is our opinion
that the Shares covered by the Registration Statement will, when issued, be
validly issued and outstanding, fully paid and nonassessable.

                  We consent to the use of this opinion as an exhibit to the
Registration Statement and to the use of our name under the caption "Legal
Matters" in the Prospectus which is part of the Registration Statement.

                                            Very truly yours,

                                            /s/ McDermott, Will & Emery
                                            McDermott, Will & Emery



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission